A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris

NCT02431052 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Olumacostat Glasaretil
OTHER: Vehicle

Sponsor

Dermira, Inc.